Clinical trial · Interventional
CT Screening For Lung Cancer in High Risk Patients: the Russian Study.
Cohort Study of Low Dose Computed Tomography for Lung Cancer Screening in Asymptomatic High-risk Patients.
NCT01752647CI-TRIAL-00040373completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This prospective cohort trial was planned to assess the feasibility of establishing a lung cancer screening program in Russian Federation using low-dose CT scanning in asymptomatic patients with at least a 30 pack-year history of cigarette smoking.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Low dose computed tomography | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Low dose computed tomography
- description
- Patients will have one baseline LDCT scan.
- interventionNames
- Procedure: Low dose computed tomography
Primary outcomes (1)
- measure
- Estimate the time period for recruitment of 500 participants in LDCT screening study.
- timeFrame
- 3 months
- description
- Primary outcome measure is to assess the feasibility of establishing a lung cancer screening program in Russian Federation using low-dose CT scanning in asymptomatic patients with at least a 30 pack-year history of cigarette smoking. The main concern comes from the possibility to recruit participant for screening as small amount of information is available about lung cancer screening options for high-risk population and general practitioners in different regions of the country.
Secondary outcomes (5)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age 50-75 years * 30 or more pack-years of cigarette smoking history * Former smokers: quit smoking within the previous 10 years * Ability to tolerate CT procedure * Signed informed consent Exclusion Criteria: * Any cancer other than nonmelanoma skin cancer or carcinoma in situ in the 5 years prior to eligibility assessment * Severe uncontrolled heart, vascular, respiratory or endocrine pathology. * Life-expectancy less than 1 year * History of lung cancer * History of lung surgery. * Acute respiratory disease * Hemoptysis. * Weight loss more than 10 kg in the 12 months prior to eligibility assessment * Participation in other cancer clinical trial * Chest CT examination in the 12 months prior to eligibility assessment.
References
Publications (0)
Data not yet available
No reference posted for this study.